Albany Molecular Research, Inc. Completes Acquisition of Great Lakes Chemical Corporation Facility

27-Sep-2001

Albany Molecular Research, Inc. (Nasdaq: AMRI) announced today that it has successfully completed the purchase of Great Lakes Chemical Corporation's (NYSE: GLK) laboratory facilities in Mt. Prospect, Illinois.

AMRI first announced the signing of a definitive agreement to purchase the facility on Friday, September 21, 2001. AMRI acquired the 88,000 square foot facility near Chicago, IL for $10 million in cash.

Albany Molecular Research, Inc. is a chemistry-based drug discovery and development company, focusing on applications for new small molecule prescription drugs. The company conducts R&D projects and collaborates with many leading pharmaceutical, biotechnology and genomics companies, and is developing new chemistry technology for potential prescription drug applications.

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!